GABA AND GLUTAMATE RECEPTORS AS THERAPEUTIC TARGETS IN NEURODEGENERATIVE DISORDERS

被引：19

作者：

KROGSGAARDLARSEN, P

机构：

[1] PharmaBiotec Research Center, Department of Organic Chemistry, Royal Danish School of Pharmacy, Copenhagen, DK-2100

来源：

PHARMACOLOGY & TOXICOLOGY | 1992年 / 70卷 / 02期

关键词：

D O I：

10.1111/j.1600-0773.1992.tb00436.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：95 / 104

页数：10

共 64 条

[1]

BIGGIO G, 1990, GABA BENZODIAZEPINE

[2] TREATMENT OF ALZHEIMERS-DISEASE - MOLECULAR PATHOLOGY VERSUS NEUROTRANSMITTER-BASED THERAPY [J].

BOWEN, DM .

BRITISH JOURNAL OF PSYCHIATRY, 1990, 157 :327-330

[3]

BREHM L, 1988, DRUG NEWS PERSPECT, V1, P138

[4] INVOLVEMENT OF THE AMYGDALA GABAERGIC SYSTEM IN THE MODULATION OF MEMORY STORAGE [J].

BRIONI, JD ;

NAGAHARA, AH ;

MCGAUGH, JL .

BRAIN RESEARCH, 1989, 487 (01) :105-112

[5] MUSCIMOL INJECTIONS IN THE MEDIAL SEPTUM IMPAIR SPATIAL-LEARNING [J].

BRIONI, JD ;

DECKER, MW ;

GAMBOA, LP ;

IZQUIERDO, I ;

MCGAUGH, JL .

BRAIN RESEARCH, 1990, 522 (02) :227-234

[6]

BRUNO G, 1984, Neurology, V34, P225

[7]

BUREAU M, 1990, MOL PHARMACOL, V37, P497

[8]

Byberg J R, 1987, Drug Des Deliv, V1, P261

[9]

Christensen I. T., 1989, DRUG DES DELIVERY, V5, P57

[10]

COYLE JT, 1983, J NEUROCHEM, V41, P1

← 1 2 3 4 5 6 7 →